Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Early voting for NC primary runoff; Election Day is May 14
Recommended
End-of-grade tests: Everything you need to know about these annual exams
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Charles River Laboratories Intl
(NY:
CRL
)
232.69
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
232.69
Bid (Size)
226.66 (1)
Ask (Size)
259.98 (2)
Prev. Close
232.69
Today's Range
232.69 - 232.69
52wk Range
161.65 - 275.00
Shares Outstanding
50,396,622
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP
Today 8:00 EDT
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
April 22, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Performance
YTD
-0.67%
-0.67%
1 Month
-13.41%
-13.41%
3 Month
+7.59%
+7.59%
6 Month
+38.90%
+38.90%
1 Year
+23.12%
+23.12%
More News
Read More
Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
April 16, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Evaluating Charles River: Insights From 7 Financial Analysts
March 18, 2024
Via
Benzinga
Forecasting The Future: 4 Analyst Projections For Charles River
February 15, 2024
Via
Benzinga
Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
April 12, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
April 11, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
April 09, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River to Perform Plasmid Production for Ship of Theseus
April 04, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
April 02, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
April 01, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Publishes 2023 Corporate Citizenship Report
March 27, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
March 21, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration
March 14, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories to Present at Barclays Global Healthcare Conference
March 12, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
The Top 3 Healthcare Stocks to Buy in March 2024
March 07, 2024
Via
InvestorPlace
Betting on Bitcoin: Does Coinbase Stock’s Surge Signal a Buy?
March 07, 2024
Via
InvestorPlace
Thermo Fisher Stock Lights Up The Board, Soars 40% In 5 Months
March 06, 2024
Via
Investor's Business Daily
Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing
February 21, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells
February 20, 2024
From
Charles River Laboratories International, Inc.
Via
Business Wire
The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn’t Ignore.
February 15, 2024
Via
InvestorPlace
Stocks Rebound As Investor Focus Shifts To Earnings, Bitcoin Tops $1 Trillion Value: What's Driving Markets Wednesday?
February 14, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Charles River Laboratories Stock Surges On Upbeat Annual Outlook, But This Analyst Is Concerned
February 14, 2024
Via
Benzinga
Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 14, 2024
Via
Benzinga
Charles River Laboratories International Posts Upbeat Results, Joins Robinhood, Zillow, Tower Semiconductor And Other Big Stocks Moving Higher On Wednesday
February 14, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.